- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 1067KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 526KB)
Vericiguat – March 2022
Vericiguat: Tablet 2.5 mg, Tablet 5 mg, Tablet 10 mg; Verquvo®
Last updated
15 July 2022